Skip to main content
Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)
India flag India · Delayed Price · Currency is INR
1,748.00
-19.20 (-1.09%)
May 9, 2025, 3:29 PM IST

NSE:SUNPHARMA Revenue

Sun Pharmaceutical Industries had revenue of 136.75B INR in the quarter ending December 31, 2024, with 10.46% growth. This brings the company's revenue in the last twelve months to 516.03B, up 8.76% year-over-year. In the fiscal year ending March 31, 2024, Sun Pharmaceutical Industries had annual revenue of 484.97B with 10.51% growth.

Revenue (ttm)
516.03B
Revenue Growth
+8.76%
P/S Ratio
8.22
Revenue / Employee
12.00M
Employees
43,000
Market Cap
4,240.10B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2024484.97B46.11B10.51%
Mar 31, 2023438.86B52.31B13.53%
Mar 31, 2022386.54B51.56B15.39%
Mar 31, 2021334.98B6.61B2.01%
Mar 31, 2020328.38B37.72B12.98%
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro
Mar 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Divi's Laboratories 90.78B
Cipla 267.20B
Apollo Hospitals Enterprise 211.46B
Mankind Pharma 116.41B
Zydus Lifesciences 222.47B
Aurobindo Pharma 309.22B
Alkem Laboratories 127.57B
Fortis Healthcare 75.61B
Revenue Rankings

Sun Pharmaceutical Industries News

More News